S'abonner

Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease - 27/02/13

Doi : 10.1016/j.jaci.2012.09.024 
Maxie Kohler, PhD a, , AnnSofi Sandberg, MSc a, Sanela Kjellqvist, PhD b, , Andreas Thomas, PhD c, Reza Karimi, MD a, Sven Nyrén, MD, PhD a, Anders Eklund, MD, PhD a, Mario Thevis, PhD c, C. Magnus Sköld, MD, PhD a, Åsa M. Wheelock, PhD a,
a Respiratory Medicine Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet/University Hospital, Stockholm, Sweden 
b Atherosclerosis Research Unit, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden 
c Center for Preventive Doping Research/Institute of Biochemistry, German Sport University Cologne, Cologne, Germany 

Corresponding author: Åsa M. Wheelock, PhD, Lung Research Lab L4:01, Respiratory Medicine Unit, Department of Medicine, Karolinska Institutet, 17176 Stockholm, Sweden.Maxie Kohler, PhD, Physical Chemistry Department, University of Cologne, Luxemburger Str 116, 50939 Cologne, Germany.

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and is increasing, primarily among women. Underdiagnosis is common, and because of the heterogeneous disease characteristics, molecular markers of specific disease phenotypes and more efficacious treatment regimens are urgently needed.

Objective

In this study the soluble proteome of bronchoalveolar lavage cells, primarily consisting of macrophages, was investigated with the aim of identifying phenotypic differences in early disease development.

Methods

Two-dimensional difference gel electrophoresis was used for relative quantification of protein levels, and multivariate modeling was applied to identify proteins of interest that were subsequently identified by means of liquid chromatography–mass spectrometry.

Results

Significant gender differences were unveiled, with numerous alterations in the bronchoalveolar lavage cell proteome occurring in female but not male patients with COPD. Specifically, a subset of 19 proteins provided classification of female healthy smokers from female patients with COPD with 78% predictive power. Subsequent pathway analyses linked the observed alterations to downregulation of the lysosomal pathway and upregulation of the oxidative phosphorylation pathway, possibly linking dysregulation of macroautophagy to a female-dominated COPD disease phenotype.

Conclusion

This investigation makes an important contribution to the elucidation of putative molecular mechanisms underlying gender-based differences in the pathophysiology of COPD, linking alterations of specific molecular pathways to previously observed gender differences in clinical COPD phenotypes. Furthermore, these results stress the importance of the gender-specific search for biomarkers, diagnosis, and treatment in COPD.

Le texte complet de cet article est disponible en PDF.

Key words : Chronic obstructive pulmonary disease, alveolar macrophage, proteomics, multivariate modeling, gender, difference gel electrophoresis, bronchoalveolar lavage

Abbreviations used : BAL, COPD, CV-ANOVA, 2D-DIGE, 2DE, FDR, GOLD, OPLS, PCA, PLS, SUS, VIP


Plan


 Supported by the Swedish Heart-Lung Foundation, the Swedish Foundation for Strategic Research (SSF), VINNOVA (VINN-MER), EU Fp6 Marie Curie, the Karolinska Institutet, AFA Insurances for financial support, the King Oscar II Jubilee Foundation, the Mats Kleeberg Foundation, King Gustaf V’s, and Queen Victoria’s Freemasons, and Hesselman’s Foundations, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council, and the Karolinska Institutet.
 Disclosure of potential conflict of interest: M. Kohler has received grants from the Karolinska Institutet and AFA Insurances. S. Kjellqvist has received grants from the Swedish Research Council. A. Eklund has received grants from the Swedish Heart Lung Foundation. A. M. Wheelock has received grants from the Swedish Heart Lung Foundation, the Swedish Foundation for Strategic Research, VINNOVA, EU Fp6 Marie Curie, and the King Oscar II Jubilee Foundation. The rest of the authors declare that they have no relevant conflicts of interest.


© 2012  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 131 - N° 3

P. 743 - mars 2013 Retour au numéro
Article précédent Article précédent
  • Prenatal and postnatal bisphenol A exposure and asthma development among inner-city children
  • Kathleen M. Donohue, Rachel L. Miller, Matthew S. Perzanowski, Allan C. Just, Lori A. Hoepner, Srikesh Arunajadai, Stephen Canfield, David Resnick, Antonia M. Calafat, Frederica P. Perera, Robin M. Whyatt
| Article suivant Article suivant
  • A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis
  • Emma L. Beckett, Richard L. Stevens, Andrew G. Jarnicki, Richard Y. Kim, Irwan Hanish, Nicole G. Hansbro, Andrew Deane, Simon Keely, Jay C. Horvat, Ming Yang, Brian G. Oliver, Nico van Rooijen, Mark D. Inman, Roberto Adachi, Roy J. Soberman, Sahar Hamadi, Peter A. Wark, Paul S. Foster, Philip M. Hansbro

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.